Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms.

Losartan normalized elevated Tsp1 abundance, although the changes did not reach statistical significance due to high levels of variation in all three groups ( Supplementary Table S1 ).

also in 111,027 other papers